US officials say two new wreath vaccines can be provided to the public before Christmas

Summary

[Funcionarios estadounidenses dijeron que se pueden proporcionar al público dos nuevas vacunas corona antes de Navidad]US Secretary of Health and Human Services Alex Aza said in an interview with US media on November 30 that if the relevant new corona vaccine is authorized for emergency use The application is approved, the United States may provide two new Vaccines crowns the public before Christmas. Aza said that the US Food and Drug Administration’s external advisory group will review the emergency use authorization request for the new corona vaccine submitted by Pfizer Pharmaceuticals in the United States on December 10. If all goes well, the application can be approved in the next few days. Additionally, the new Modena corona vaccine can be approved one week later than the Pfizer vaccine. (Xinhua News Agency)

US Health ANDpublicServiceMinister Alex Azza on November 30to acceptThe US media said in an interview that if the new relevant corona vaccine is used urgentlyAuthorizationThe application is approved, the United States can provide two new corona vaccines to the public before Christmas.

Aza said that American food and medicineadministrationThe Office’s external advisory group will review the United States on December 10.PfizerLimited pharmaceuticalthe companyEmergency use authorization request submitted for the new corona vaccine. If all goes well, the application can be approved in the next few days.In addition, the new Modena corona vaccine can bePfizerThe vaccine was approved a week later. The vaccine will begin shipping across the United States within 24 hours of approval.

Aza said the U.S. federal government will deliver vaccines through its normal vaccine delivery system, and the governors of each state are responsible for determining where vaccines will be shipped first and which populations will be prioritized. the Centers for Disease Control and Prevention will do.groupGive advice on priority vaccination.

　　PfizerThe new corona vaccine developed jointly by the company and the German biotechnology company is an mRNA (messenger ribonucleic acid) vaccine. The two companies announced on November 18 that the results of phase 3 clinical trials showed that this vaccine is 95% effective in preventing new coronavirus infections. On November 20, the two companies submitted an emergency use authorization request to the US Drug Administration.

Modena and the National Institute of Allergy and Infectious DiseasesCooperative research and developmentThe new corona vaccine is also an mRNA vaccine. Modena issued a statement on November 30 that the results of the phase 3 clinical trial showed that the effectiveness of the vaccine in preventing new coronavirus infections reached 94.1%. The company plans to submit an emergency use authorization request to the US Drug Administration on the same day.

(Source: Xinhua News Agency)

(Editor in charge: DF078)